ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CRL Charles River Laboratories International Inc

206.58
-0.77 (-0.37%)
29 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Charles River Laboratories International Inc NYSE:CRL NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.77 -0.37% 206.58 209.695 204.43 205.92 666,758 00:55:02

Charles River Laboratories to Present at William Blair and Jefferies Conferences

03/06/2024 1:00pm

Business Wire


Charles River Laboratories (NYSE:CRL)
Historical Stock Chart


From Jun 2024 to Jun 2024

Click Here for more Charles River Laboratories Charts.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4th, at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Conference on Wednesday, June 5th, at 10:00 a.m. ET. Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Investor Relations Contact: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 todd.spencer@crl.com

1 Year Charles River Laboratories Chart

1 Year Charles River Laboratories Chart

1 Month Charles River Laboratories Chart

1 Month Charles River Laboratories Chart